A B S T R A C T An inactive form of renin has been isolated from human plasma. It has been suggested that this may represent renin precursor secreted from the kidney. However, early studies failed to isolate inactive renin from human renal tissue. In this investigation, rapid processing of human kidney cortex at temperatures below 40C in the presence of protease inhibitors followed by cibacron-blue affinity chromatography allowed us to extract a totally inactive form of renal renin. Furthermore, we found that in kidney inactive renin constituted from 10 to as much as 50% of the total renin concentration. Biochemical characterization of the inactive renin from plasma and from kidney indicates that they are structural homologues and, when activated, have enzymatic properties that resemble active renal renin. Renal and plasma inactive renin were found to have the following properties in common: (a) a pH optimum of activation of 3.3; (b) reversible activation by acid dialysis on return to pH 7.4, 370C; (c) pH optima of enzyme activity of 7.8 with sheep angiotensinogen and 5.5 and 6.7 (biphasic) with human angiotensinogen; (d) Michaelis-Menten constants, Km, of 0.29-0.34 AM with sheep angiotensinogen, and 0.99-1.25 AM with human angiotensinogen; (e) an antibody to human renal renin mean inhibitory titer of 1:30,000 with 1
INTRODUCTION
Pulse labeling studies in isolated canine glomeruli (1) and studies in cell-free translation systems using mouse submaxillary gland and kidney (2-4) have demonstrated that renin, like most enzymes and polypeptide hormones, is synthesized as a proform, i.e., prorenin. Precursor renin is larger in molecular size than active renin, but little more is known about its biochemistry. In general, proenzymes have no biologic activity and are converted to active enzymes by limited proteolysis (5) . Early investigations have been unable to document the presence of a renin zymogen in human kidney tissue (6) . However, in man an inactive form of renin constitutes more than half of the total renin concentration in plasma (6) . This inactive renin has a larger apparent molecular weight than active renin and can be activated to the same degree by either acid or pro-teolytic treatment of plasma (7) . It has been postulated that circulating inactive renin may be renin precursor. However, definitive proof is lacking, and the origin of inactive renin is unknown. Furthermore, characterization of inactive renin has been difficult because of the small quantities in plasma.
Successful identification of an inactive form of renin in the kidney and demonstration of a venous-arterial gradient would provide strong support that plasma inactive renin is, at least in part, of renal origin. In addition, the finding of high levels of inactive renin in the kidney would provide a source for its purification, which is necessary for further studies to critically examine the possible precursor role of inactive renin. Recent understanding of the properties and stability of inactive renin has lead to improved conditions of extraction of inactive renin from tissue sources. As a result, Atlas et al. (8) , Chang et al. (9) , and our laboratory (10) have reported the isolation of a completely inactive form of renin from human renal cortex. The purpose of this study was (a) to provide a detailed analysis of the quantitative relationship between active and inactive renin within the kidney and plasma; (b) to compare activation characteristics and biochemical properties of renal and plasma inactive renin; and (c) to determine whether renal inactive renin is released into the plasma.
Based on six criteria, we found that renal and plasma inactive renin shared remarkable similarities. The use of different activation techniques may have resolved some of the molecular weight discrepancies previously reported between plasma and renal inactive renin (8, 9) . Several methods used in this study also emphasize the heterogeneity of human inactive renin. In addition, use of converting enzyme inhibition allowed the first demonstration of a highly significant gradient of inactive renin across the kidney.
METHODS

Extraction of inactive renin
Blood. Plasma was obtained (11) from five volunteers on unrestricted sodium intake. Inactive renin was extracted from plasma by affinity chromatography on cibacron-blue agarose (Bio-Rad Laboratories, Richmond, CA) and eluted with a stepwise increase in NaCl concentration (12, 13 (7, 15) .
The effect of renal kallikrein on human inactive renin was evaluated by incubating samples with partially purified human renal kallikrein (2.3 IU/ml sample) at 25°C for 1 h, pH 7.5 (16) .
Preparation of renin-free human angiotensinogen
Human angiotensinogen from plasma of a subject ingesting oral contraceptives was prepared by ammonium sulfate precipitation (17) . Plasma containing 5 mM EDTA was adjusted to 1.5 M (NH4)2SO4 by addition of solid ammonium sulfate, stirred for 18 h and centrifuged at 5,000 g for 30 min. The precipitant was washed twice with 1.5 M (NH4)2SO4. The supernates were combined, adjusted to 2.3 M (NH4)2SO4 and stirred for 4 h. Following centrifugation, the precipitate was dissolved in distilled water and exhaustively dialyzed against distilled water. All processing occurred at 4°C. The final preparation had a substrate concentration of 5,400 ng AI/ml and did not possess renin activity.
Angiotensinogen concentration was determined by the method of Skinner et al. (18 of substrate hydrolysis at all substrate concentrations. In addition, three time periods of Al generation were used to ensure constant velocity during the reaction. LineweaverBurke analysis was applied to the data, and each K. was determined in triplicate using the statistical method of Wilkinson (19) .
Gel filtration. Renal or plasma inactive renin isolated by cibacron-blue affinity chromatography was placed on a 2.5 X 85-cm column of Sephadex G-100 (Pharmacia Fine Chemicals) at pH 7.5 with a flow rate of 12 ml/h at 4°C. Elution was expressed as the partition coefficient, Ka. (20) . Standards used for column calibration included bovine serum albumin, ovalbumin, a-chymotrypsinogen (Sigma Chemical Co., St. Louis, MO) with molecular weights of 67,000, 44 ,000, and 23,200, respectively. Apparent molecular weight was estimated from a semilogarithmic plot of K., vs. molecular weight.
Inhibition by anti-human renal renin antibody. Renin specific antibody (R1723) was obtained in a rabbit immunized with human renal renin, purified to homogeneity by a modification of our previously described method (21 
RESULTS
Inactive renin in human renal cortex
In homogenates from three surgical specimens of renal cortex, inactive renin as demonstrated by acid activation comprised from 10 to 46% of the total renin concentration. In three cadaver kidneys as much as 53% of the total renin was inactive (Table I) .
A representative cibacron-blue elution pattern (specimen 1B in Table 1 ) of active and inactive renin in the homogenates of fresh kidney is shown in Fig. 1A . Most of the active renin did not bind to cibacron-blue, and negligible amounts of inactive renin were detected in the unbound fractions. In all specimens, the bound inactive renin eluted at 0.5 M NaCl. In specimen 1 from fresh tissue and specimen 1 of cadaver tissue, which contained the highest percentages of inactive renin, little or no active renin was detected in the bound fractions. In specimens 2 and 3 from fresh tissue, approximately half of the bound renin was active, but rechromatography of the bound fractions on cibacron-blue decreased the percentage of active renin that bound to the column. Recovery of active and inactive renin from the cibacron-blue column ranged from 47 to 100%. Chromatography on cibacron-blue enhanced the specific activity of activated inactive renal renin 7-to 40-fold. Trypsin treatment of the bound fractions, using the procedure of Atlas et al. We also measured inactive renin in a 1-kg preparation (-20 kidneys) of human renal cortex (21) . Either acid or trypsin treatment after homogenization and DEAE batch chromatography yielded significant increases in renin activity. Inactive renin comprised 40-80% of the total renin concentration.
Inactive renin in human plasma
When plasma from a normal subject, containing an active renin concentration of 14 ng/ml per h, was chromatographed on cibacron-blue, active renin in plasma did not bind, but inactive renin bound and eluted at 0.5 M NaCl (Fig. 1B) . Inactive renin was separated from human serum albumin, which eluted at 1.5 M NaCl. The specific activity of activated plasma renin increased 130-fold by cibacron-blue affinity chromatography. Further characterization of plasma inactive renin was based on a pool of the bound fractions from this plasma.
Inactive renin concentration in plasma of the three patients with renal tumor before nephrectomy ranged from 40 to 60 ng/ml per h (Table II) , consistent with normal values (20) . Therefore, the renal tumors in these patients did not appear to secrete large amounts of inactive renin into the circulation.
Effect of acid and renal kallikrein on renal and plasma inactive renin Both renal and plasma inactive renin were maximally activated by dialysis against pH 3.3 buffer at 40C for 24 h. A graph of pH of dialysis vs. percent total renin resembled a titration curve with an approximate pKa of 3.5 (Fig. 2) Patient number corresponds to the fresh kidney tissue number in Table I. in Fig. 3 and are identical to the behavior of plasma inactive renin (15 Gel filtration. Elution patterns of cibacron-blue preparations of renal and plasma inactive renin on Sephadex G-100 are illustrated in Fig. 6 . When fractions were dialyzed to pH 3.3 and subsequently neutralized by titration, two definite peaks of inactive renin were seen in both kidney and plasma preparations. In three elutions of renal inactive renin from specimen 1 and one elution of specimen 2 on Sephadex G-100, the first peak had an apparent mol wt of 56,300±1,500 (mean±SEM) and the second peak had an apparent mol wt of 49,200±1,000. Recovery of total renal renin following gel filtration was 90±12%. Activation of renal inactive renin by acid plus renal kallikrein treatment resulted in no change in the elution pattern from Sephadex G-100. In addition, a small shoulder of activity eluted immediately ahead of the first peak in both chromatograms. The significance of this is unclear at present. In plasma, the peaks of inactive renin had an apparent mol wt of 58,000 and 49,000, respectively. Recovery of total renin from plasma was 90%. The presence of inactive renin under these peaks was confirmed by activation of renin in the eluates with acid plus pepsin treatment (7) . When (6, 15) . In this study, we found that inactive renin comprised from 10 to 50% of the total renin concentration in human renal cortex, and even greater percentages were found in large scale processing of human kidneys. These values may underestimate the actual quantities of renin in the kidney, since during isolation, some activation of renin may have occurred by several endogenous renal enzymes (25, 26) . We have also demonstrated that renal and plasma inactive renin are virtually identical in physiochemical, kinetic, and immunogenic properties (Table III) . These similarities have emerged despite the use of only partially purified preparations of plasma and renal inactive renin, which could contain variable quantities of enzymes and other proteins that might affect activation and characterization. These findings are consistent with the postulate that plasma inactive renin arises from the kidney and are supported (a) by the present observations demonstrating a gradient of inactive renin in IVC and renal vein blood and (b) by the report of Atlas et al. (8) who found inactive renin in the perfusate of an isolated human kidney.
Recent investigations have shown that reversible acid activation is a unique property of plasma inactive renin (15, 27) , which is probably due to a conformational change in human renin (15) . Renal kallikrein, implicated as a potential in vivo activator of renin (28), can prevent reversal of acid activation at neutral pH by maintaining acid-exposed renin in an active conformation. Since our results demonstrate that the effects of low pH and renal kallikrein on renal inactive renin are the same as that on plasma inactive renin, it would appear that the tertiary structure of both inactive renins is similar. Antibody to pure human active renal renin completely neutralized the activity of activated plasma and renal inactive renin also suggesting a high degree of structural homology between these molecules. The demonstration that the inhibitory titer of the antibody for both active MRC renin and activated renal and plasma inactive renin were indistinguishable, strongly suggests that the active sites of the enzymes are essentially identical.
Kinetic and antibody inhibition studies also suggest that an enzyme homologous to endogenous active renal renin may be derived from in vitro activations of inactive renin. Activation of both renal and plasma inactive renin yielded an active enzyme with similar kinetic behavior to a standard preparation of active renal renin (MRC). All three renins displayed the same patterns of enzyme activity with two different substrates prepared from sheep and human plasma. Two substrates were used in order to eliminate the possibility that results were biased because of peculiarities of the substrate preparation and to evaluate the renin reaction with two commonly used substrates in which renin hydrolyzed different peptide bonds. Renin splits a valine-leucine bond in human angiotensinogen and a leucine-leucine bond in other mammalian substrates to liberate the same decapeptide (29) . The Km of all three renins with each of the substrates was the same, again suggesting that the active site of the renins originating from different sources is not significantly different. The Km with sheep substrate was 0.29-0.34 ,MM and with human substrate was 0.99-1.39 uM; these agree with previously reported values for active forms of plasma and renal renin (14, (30) (31) (32) In addition to enzyme activity, investigation of pH optima and gel filtration lend strong support to the identity of plasma and renal inactive renin. Another important observation stemming from these studies is the demonstration that human plasma and renal inactive renin exist in multiple forms. Activated renal and plasma inactive renin had a pH optimum of 7.8 with sheep angiotensinogen, and pH optima of 5.5 and 6.7 with human angiotensinogen. This biphasic pattern with human substrate could result from the presence of several forms of inactive renin or from heterogeneity of the renal substrate in plasma of women ingesting oral contraceptives (33) .
Gel filtration displayed two distinct peaks, and possibly a third peak, of inactive renin in both plasma and kidney. In previous studies, in which we applied normal plasma to a Sephadex G-100 column, only a single peak of inactive renin of 55,000-mol wt was described (7) . In this study, improved resolution of potential renin peaks was possible since partially purified inactive renin was placed on the G-100 column. The peaks in plasma correlated to those in kidney, 56,000±1,500 and 49,200±1,000. In contrast, Atlas et al. (8) and Chang et al. (9) described a single peak of plasma and renal inactive renin of 56,000-and 50,000-mol wt, respectively. Both groups used trypsin treatment to define inactive renin, and we have confirmed these estimates using trypsin. Because excess trypsin destroys renin (6) , its optimum concentration for renin activation varies from eluate to eluate due to variable elution of trypsin inhibitors and other proteins. Using trypsin, multiple peaks of inactive renin may be difficult to detect. We have defined inactive renin in column eluates by a modified acid-activation technique, which does not appear to be mediated by proteases (15) . This approach yields good recoveries of inactive renin. Therefore, it may have advantage over other methods accompanied by proteolytic destruction of renin.
Both peaks of inactive renin have immunoidentity to active renal renin. These peaks could represent two distinct forms of inactive renin that differ in amino acid composition. Alternatively, differences in glycosylation or conformation could contribute to variations in Stokes' radius to account for differences in apparent molecular weight. A less likely possibility is that the peaks represent partially degraded inactive renins following extraction and chromatography. Renal and plasma inactive renin have previously been shown to have similar sets of isoelectric points (9) , and active renin has similarly been demonstrated to be heterogenous (31, 34) . More recent studies from our laboratory using pulse-labeling techniques show that multiple forms of renin are synthesized and released (35, 36) . The current findings help to explain the discrepancy generated by observations reporting significant differences in apparent molecular weight between plasma and renal inactive renin and may represent biochemical counterparts to the pulse-labeling experiments. However, data derived from the present studies cannot distinguish whether inactive renin is a precursor of active renin or an active renin-inhibitor complex.
To strengthen the hypothesis that the kidney is a source of plasma inactive renin, we looked for differences in inactive renin concentration in IVC and renal vein blood. Since there is no evidence that there are differences in renin concentration in arterial blood and IVC blood below the renal veins, the renin concentration in the IVC below the renal veins has been generally accepted to reflect the renal arterial concentration (37) . We found a small but significant increase in inactive renin in renal venous blood compared with IVC below the kidney, similar to some previous reports (38, 39) . Other studies, however, have been less consistent in demonstrating such a renal gradient (40) . Since chronic inhibitor of converting enzyme induces a fourfold increase in circulating inactive renin (41), we also measured renal vein inactive renin in four patients during chronic administration of captopril. The exact mechanism by which captopril stimulates inactive renin production is unclear. Nevertheless, inactive renin concentration across the kidney increased by -250% as compared with 38% in the unstimulated group. In view of the 15% intraassay coefficient of variation, the increase in inactive renin during stimulation is highly significant. Therefore, we have demonstrated a consistent gradient of inactive renin across the kidney.
In summary, extensive characterization of plasma and renal inactive renin and measurement of a renal gradient of inactive renin indicate that the kidney is a likely source of circulating inactive renin. Therefore, plasma levels of active and inactive renin may reflect renal secretion of the two forms of renin. Certain physiologic and pathologic conditions are accompanied by alterations of the inactive/active renin ratio in plasma (42) (43) (44) . Thus, further investigation of the relationships between plasma and tissue active and inactive renins promises to be important in defining the pathophysiology of renin production in man.
